AAAAAA

   
Results: 1-18 |
Results: 18
REPEATED-DOSE PHARMACOKINETICS OF AN ORAL SOLUTION OF ITRACONAZOLE ININFANTS AND CHILDREN
Authors: DEREPENTIGNY L RATELLE J LECLERC JM CORNU G SOKAL EM JACQMIN P DEBEULE K
Citation: L. Derepentigny et al., REPEATED-DOSE PHARMACOKINETICS OF AN ORAL SOLUTION OF ITRACONAZOLE ININFANTS AND CHILDREN, Antimicrobial agents and chemotherapy, 42(2), 1998, pp. 404-408
PHYSIOLOGICAL RED-BLOOD-CELL KINETIC-MODEL TO EXPLAIN THE APPARENT DISCREPANCY BETWEEN ADENOSINE BREAKDOWN INHIBITION AND NUCLEOSIDE TRANSPORTER OCCUPANCY OF DRAFLAZINE
Authors: SNOECK E DONCK KV JACQMIN P VANBELLE H DUPONT AG VANPEER A DANHOF M
Citation: E. Snoeck et al., PHYSIOLOGICAL RED-BLOOD-CELL KINETIC-MODEL TO EXPLAIN THE APPARENT DISCREPANCY BETWEEN ADENOSINE BREAKDOWN INHIBITION AND NUCLEOSIDE TRANSPORTER OCCUPANCY OF DRAFLAZINE, The Journal of pharmacology and experimental therapeutics, 286(1), 1998, pp. 142-149
POPULATION ANALYSIS OF THE NON-LINEAR RED-BLOOD-CELL PARTITIONING ANDTHE CONCENTRATION-EFFECT RELATIONSHIP OF DRAFLAZINE FOLLOWING VARIOUSINFUSION RATES
Authors: SNOECK E PIOTROVSKIJ V JACQMIN P VANPEER A DANHOF M DONCK KV WOESTENBORGHS R VANBELLE H VANBORTEL L VANGOOL R DUPONT AG HEYKANTS J
Citation: E. Snoeck et al., POPULATION ANALYSIS OF THE NON-LINEAR RED-BLOOD-CELL PARTITIONING ANDTHE CONCENTRATION-EFFECT RELATIONSHIP OF DRAFLAZINE FOLLOWING VARIOUSINFUSION RATES, British journal of clinical pharmacology, 43(6), 1997, pp. 603-612
POPULATION ANALYSIS OF THE NONLINEAR RED-BLOOD-CELL PARTITIONING OF DRAFLAZINE FOLLOWING VARIOUS INFUSION DURATIONS
Authors: SNOECK E PIOTROVSKIJ V JACQMIN P LINS RL VANPEER A DANHOF M WOESTENBORGHS R VANGOOL R DUPONT AG HEYKANTS J
Citation: E. Snoeck et al., POPULATION ANALYSIS OF THE NONLINEAR RED-BLOOD-CELL PARTITIONING OF DRAFLAZINE FOLLOWING VARIOUS INFUSION DURATIONS, European Journal of Clinical Pharmacology, 53(1), 1997, pp. 57-63
HYDROXYPROPYL CYCLODEXTRINS - POTENTIAL SYNERGISM WITH CARCINOGENS - COMMENTARY
Authors: VANCAUTEREN H JACQMIN P COUSSEMENT W MEULDERMANS W LAMPO A LAMMENS L
Citation: H. Vancauteren et al., HYDROXYPROPYL CYCLODEXTRINS - POTENTIAL SYNERGISM WITH CARCINOGENS - COMMENTARY, Journal of pharmaceutical sciences, 86(3), 1997, pp. 402-403
THE EFFECT OF COADMINISTRATION OF A COLA BEVERAGE ON THE BIOAVAILABILITY OF ITRACONAZOLE IN PATIENTS WITH ACQUIRED-IMMUNODEFICIENCY-SYNDROME
Authors: LANGE D PAVAO JH JACQMIN P WOESTENBORGHS R DING C KLAUSNER M
Citation: D. Lange et al., THE EFFECT OF COADMINISTRATION OF A COLA BEVERAGE ON THE BIOAVAILABILITY OF ITRACONAZOLE IN PATIENTS WITH ACQUIRED-IMMUNODEFICIENCY-SYNDROME, Current therapeutic research, 58(3), 1997, pp. 202-212
THE IMPLICATIONS OF NONLINEAR RED-BLOOD-CELL PARTITIONING FOR THE PHARMACOKINETICS AND PHARMACODYNAMICS OF THE NUCLEOSIDE TRANSPORT INHIBITOR DRAFLAZINE
Authors: SNOECK E JACQMIN P VANPEER A DANHOF M VERDONCK K VANBELLE H WOESTENBORGHS R CRABBE R VANGOOL R DUPONT A HEYKANTS J
Citation: E. Snoeck et al., THE IMPLICATIONS OF NONLINEAR RED-BLOOD-CELL PARTITIONING FOR THE PHARMACOKINETICS AND PHARMACODYNAMICS OF THE NUCLEOSIDE TRANSPORT INHIBITOR DRAFLAZINE, British journal of clinical pharmacology, 42(5), 1996, pp. 605-613
ANTIFUNGAL PULSE THERAPY FOR ONYCHOMYCOSIS - A PHARMACOKINETIC AND PHARMACODYNAMIC INVESTIGATION OF MONTHLY CYCLES OF 1-WEEK PULSE THERAPY WITH ITRACONAZOLE
Authors: DEDONCKER P DECROIX J PIERARD GE ROELANT D WOESTENBORGHS R JACQMIN P ODDS F HEREMANS A DOCKX P ROSEEUW D
Citation: P. Dedoncker et al., ANTIFUNGAL PULSE THERAPY FOR ONYCHOMYCOSIS - A PHARMACOKINETIC AND PHARMACODYNAMIC INVESTIGATION OF MONTHLY CYCLES OF 1-WEEK PULSE THERAPY WITH ITRACONAZOLE, Archives of dermatology, 132(1), 1996, pp. 34-41
CHARACTERIZATION OF BINDING OF AN RGD MIMETIC, [H-3] SC-52012, TO PLATELET GPIIB IIIA/
Authors: PANZERKNODLE SG JACQMIN P PAGE JD NICHOLSON NS ZABLOCKI JA ENGLEMAN VW FEIGEN LP
Citation: Sg. Panzerknodle et al., CHARACTERIZATION OF BINDING OF AN RGD MIMETIC, [H-3] SC-52012, TO PLATELET GPIIB IIIA/, Platelets, 6(5), 1995, pp. 288-295
PARADOXICAL RESPONSE TO ITRACONAZOLE TREATMENT IN A PATIENT WITH ONYCHOMYCOSIS CAUSED BY MICROSPORUM-GYPSEUM
Authors: PIERARDFRANCHIMONT G DEDONCKER P VANDEVELDE V JACQMIN P ARRESE JE PIERARD GE
Citation: G. Pierardfranchimont et al., PARADOXICAL RESPONSE TO ITRACONAZOLE TREATMENT IN A PATIENT WITH ONYCHOMYCOSIS CAUSED BY MICROSPORUM-GYPSEUM, Annales de la Societe belge de medecine tropicale, 75(3), 1995, pp. 211-217
A STUDY OF LACTATE METABOLISM WITHOUT TRACER DURING PASSIVE AND ACTIVE POSTEXERCISE RECOVERY IN HUMANS
Authors: FRANCAUX M JACQMIN P DEWELLE JM STURBOIS X
Citation: M. Francaux et al., A STUDY OF LACTATE METABOLISM WITHOUT TRACER DURING PASSIVE AND ACTIVE POSTEXERCISE RECOVERY IN HUMANS, European journal of applied physiology and occupational physiology, 72(1-2), 1995, pp. 58-66
POTENT IN-VITRO AND IN-VIVO INHIBITORS OF PLATELET-AGGREGATION BASED UPON THE ARG-GLY-ASP SEQUENCE OF FIBRINOGEN - (AMINOBENZAMIDINO)SUCCINYL (ABAS) SERIES OF ORALLY-ACTIVE FIBRINOGEN RECEPTOR ANTAGONISTS
Authors: ZABLOCKI JA RICO JG GARLAND RB ROGERS TE WILLIAMS K SCHRETZMAN LA RAO SA BOVY PR TJOENG FS LINDMARK RJ TOTH MV ZUPEC ME MCMACKINS DE ADAMS SP MIYANO M MARKOS CS MILTON MN PAULSON S HERIN M JACQMIN P NICHOLSON NS PANZERKNODLE SG HAAS NF PAGE JD SZALONY JA TAITE BB SALYERS AK KING LW CAMPION JG FEIGEN LP
Citation: Ja. Zablocki et al., POTENT IN-VITRO AND IN-VIVO INHIBITORS OF PLATELET-AGGREGATION BASED UPON THE ARG-GLY-ASP SEQUENCE OF FIBRINOGEN - (AMINOBENZAMIDINO)SUCCINYL (ABAS) SERIES OF ORALLY-ACTIVE FIBRINOGEN RECEPTOR ANTAGONISTS, Journal of medicinal chemistry, 38(13), 1995, pp. 2378-2394
SC-54684A - AN ORALLY-ACTIVE INHIBITOR OF PLATELET-AGGREGATION
Authors: NICHOLSON NS PANZERKNODLE SG SALYERS AK TAITE BB SZALONY JA HAAS NF KING LW ZABLOCKI JA KELLER BT BROSCHAT K ENGLEMAN VW HERIN M JACQMIN P FEIGEN LP
Citation: Ns. Nicholson et al., SC-54684A - AN ORALLY-ACTIVE INHIBITOR OF PLATELET-AGGREGATION, Circulation, 91(2), 1995, pp. 403-410
CHARACTERIZATION OF A PEPTIDE MIMETIC LIGAND ([3H]SC-52012) BINDING TO PLATELET GP IIB IIIA RECEPTOR/
Authors: PAGE JD PANZERKNODLE SG JACQMIN P NICHOLSON NS ZABLOCKI JA ENGLEMAN VW FEIGEN LP
Citation: Jd. Page et al., CHARACTERIZATION OF A PEPTIDE MIMETIC LIGAND ([3H]SC-52012) BINDING TO PLATELET GP IIB IIIA RECEPTOR/, Blood, 84(10), 1994, pp. 10000689-10000689
IRREVERSIBLE BINDING TO PROTEINS AFTER SINGLE AND REPEATED DAILY ORAL-ADMINISTRATION OF 4-(2,2-DIPHENYLETHYL) IMIDAZOLE (SC-46264) TO THE CYNOMOLGUS MONKEY
Authors: JACQMIN P HERIN M CAVALIER R LESNE M
Citation: P. Jacqmin et al., IRREVERSIBLE BINDING TO PROTEINS AFTER SINGLE AND REPEATED DAILY ORAL-ADMINISTRATION OF 4-(2,2-DIPHENYLETHYL) IMIDAZOLE (SC-46264) TO THE CYNOMOLGUS MONKEY, European journal of drug metabolism and pharmacokinetics, 18(3), 1993, pp. 299-307
AN ORALLY-ACTIVE GLYCOPROTEIN-IIB IIIA ANTAGONIST-SC-54684/
Authors: NICHOLSON N TAITE B PANZERKNODLE S SALYERS A HAAS N SZALONY J ZABLOCKI J FEIGEN L GLENN K KELLER B BROSCHAT K HERIN M JACQMIN P LESNE M
Citation: N. Nicholson et al., AN ORALLY-ACTIVE GLYCOPROTEIN-IIB IIIA ANTAGONIST-SC-54684/, Thrombosis and haemostasis, 69(6), 1993, pp. 975-975
LONG-TERM INHIBITION OF PLATELETS IN DOGS WITH THE ORALLY-ACTIVE ALPHA(IIB)BETA(3) ANTAGONIST-SC-54684
Authors: FEIGEN L NICHOLSON N TAITE B PANZERKNODLE S SALYERS A HAAS N SZALONY J ZABLOCKI J GLENN K KELLER B HERIN M JACQMIN P LESNE M
Citation: L. Feigen et al., LONG-TERM INHIBITION OF PLATELETS IN DOGS WITH THE ORALLY-ACTIVE ALPHA(IIB)BETA(3) ANTAGONIST-SC-54684, Thrombosis and haemostasis, 69(6), 1993, pp. 1071-1071
SELECTION OF AN ORALLY-ACTIVE GLYCOPROTEIN-IIB IIIA RECEPTOR ANTAGONIST FOR CLINICAL-TRIALS/
Authors: ZABLOCKI J NICHOLSON N TAITE B PANZERKNODLE S SALYERS A HAAS N SZALONY J FEIGEN L HERIN M JACQMIN P LESNE M BOVY P TJOENG FS
Citation: J. Zablocki et al., SELECTION OF AN ORALLY-ACTIVE GLYCOPROTEIN-IIB IIIA RECEPTOR ANTAGONIST FOR CLINICAL-TRIALS/, Thrombosis and haemostasis, 69(6), 1993, pp. 1244-1244
Risultati: 1-18 |